
Scientists can modify functions of genes more precisely with a new gene editing method that uses light, a new study says.
"This method may allow people to engineer genes in cells or animals with better spatial and temporal control than ever before," said researcher Alexander Deiters, University of Pittsburgh, US.
Advertisement
The improved control over the time and location at which a gene would be manipulated may help eliminate "off-target effects", Deiters said.
Since 2013, scientists have used a gene-editing tool called CRISPR/Cas9. The method employs a bacterially derived protein (Cas9) and a synthetic guide RNA to induce a double-strand break at a specific location in the genome. This enables excision of a gene, alteration of its function, or introduction of desired mutations.
In practice, the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats of DNA base sequences) method has shown tremendous promise to enable researchers to treat cystic fibrosis and sickle-cell anemia, create laboratory animals that mimic human disease, and create a strain of wheat resistant to powdery mildew.
The researchers have found that a lysine residue (lysine is an amino acid) in Cas9 can be replaced with a light-activated analog.
The new approach generates a Cas9 protein that is functionally inactive, so called "caged," until the cage is removed through light exposure, activating the enzyme and thereby activating gene editing.
"Previously, if you wanted to knock out a gene, you had limited control over where and when it would happen. Engineering a light switch into Cas9 provides a more precise editing tool," Deiters noted.
Source: Medindia
Advertisement
In practice, the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats of DNA base sequences) method has shown tremendous promise to enable researchers to treat cystic fibrosis and sickle-cell anemia, create laboratory animals that mimic human disease, and create a strain of wheat resistant to powdery mildew.
The researchers have found that a lysine residue (lysine is an amino acid) in Cas9 can be replaced with a light-activated analog.
The new approach generates a Cas9 protein that is functionally inactive, so called "caged," until the cage is removed through light exposure, activating the enzyme and thereby activating gene editing.
"Previously, if you wanted to knock out a gene, you had limited control over where and when it would happen. Engineering a light switch into Cas9 provides a more precise editing tool," Deiters noted.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News

New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.

Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.

Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.

Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.

Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.